(Q38964852)

English

Knockdown of Akt2 expression by shRNA inhibits proliferation, enhances apoptosis, and increases chemosensitivity to paclitaxel in human colorectal cancer cells

scientific article published on January 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Knockdown of Akt2 expression by shRNA inhibits proliferation, enhances apoptosis, and increases chemosensitivity to paclitaxel in human colorectal cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Zhongyang Ding

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Fei Xu

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Gan Li

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Jiandong Tang

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Zhangfeng Tang

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Panqiang Jiang

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Haotian Wu

7

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

1 January 2015

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Cell Biochemistry and Biophysics

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

71

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

383-388

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

A Systematic Overview of Radiation Therapy Effects in Rectal Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0209-9

21 January 2018

Structure, regulation and function of PKB/AKT--a major therapeutic target

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0209-9

21 January 2018

Knockdown of AKT2 expression by RNA interference inhibits proliferation, enhances apoptosis, and increases chemosensitivity to the anticancer drug VM-26 in U87 glioma cells

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0209-9

21 January 2018

Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0209-9

21 January 2018

Knockdown of cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0209-9

21 January 2018

Knockdown of Akt sensitizes osteosarcoma cells to apoptosis induced by cisplatin treatment

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0209-9

21 January 2018

The phosphoinositide 3-kinase pathway

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0209-9

21 January 2018

Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0209-9

21 January 2018

Role of translocation in the activation and function of protein kinase B

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0209-9

21 January 2018

Threonine 308 phosphorylated form of Akt translocates to the nucleus of PC12 cells under nerve growth factor stimulation and associates with the nuclear matrix protein nucleolin.

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0209-9

21 January 2018

Insulin increases the association of Akt-2 with Glut4-containing vesicles

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0209-9

21 January 2018

Akt-2 binds to Glut4-containing vesicles and phosphorylates their component proteins in response to insulin

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0209-9

21 January 2018

AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0209-9

21 January 2018

AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0209-9

21 January 2018

Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0209-9

21 January 2018

Clusterin and chemoresistance

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0209-9

21 January 2018

Novel steroid carbamates reverse multidrug-resistance in cancer therapy and show linkage among efficacy, loci of drug action and P-glycoprotein's cellular localization

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0209-9

21 January 2018

Identifiers

10.1007/S12013-014-0209-9

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38964852&oldid=2202387657"